... ZD6474 Total 1 6 17 24 18 4 3 25 19 10 20 49 Cancer Prev Res; 3(11) November 2010 Downloaded from ...
... was pharmacologically active in the 4-NQO model of OSCC. Animals treated with 25 mg/kg/d had ...
... Growth Factor Receptor is an Effective Chemopreventive Strategy in the Mouse 4-NQO Model of Oral ...
... , comprehensive treatment plans must include improved chemopreventive strategies. Using the 4-nitroquinoline 1 ...
... -oxide (4-NQO) mouse model, we tested the hypothesis that ZD6474 (Vandetanib, ZACTIMA) is an effective ...